文献速递心力衰竭与心肌病

心内科重症监护病房中休克团队与无休克团队的心源性休克管理与结局比较

Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

该多中心观察性研究纳入北美24个心脏重症监护病房的1242例心源性休克入院患者,比较有休克团队与无休克团队中心的实践模式和结局。休克团队中心更多使用肺动脉导管和先进机械循环支持,且心内科重症监护病房死亡率更低(23% vs 29%;调整OR 0.72;95%CI 0.55-0.94;P=0.016)。

要点

  • 休克团队中心更多使用肺动脉导管(60% vs 49%;调整OR 1.86;95%CI 1.47-2.35;P<0.001)。
  • 休克团队中心总体机械循环支持使用更少(35% vs 43%;调整OR 0.74;95%CI 0.59-0.95;P=0.016),但先进类型比例更高(53% vs 43%;调整OR 1.73;95%CI 1.19-2.51;P=0.005)。
  • 休克团队存在与更低的心内科重症监护病房死亡率独立相关(23% vs 29%;调整OR 0.72;95%CI 0.55-0.94;P=0.016)。

核心结论

  • 在多中心观察性研究中,有休克团队的中心更可能获取侵入性血流动力学、使用先进类型机械循环支持,并具有更低的风险调整死亡率。

研究设计与样本

  • Critical Care Cardiology Trials Network为北美多中心心脏重症监护病房网络,在2017-2019年每年2个月收集期纳入24个中心所有连续内科入院患者(n=6,872)。
  • 采用逆概率加权比较有休克团队与无休克团队中心之间的休克管理和心内科重症监护病房死亡率。

主要发现

  • 两组在人口学、休克病因、序贯器官衰竭评估评分、终末器官功能障碍生化标志物和侵入性血流动力学方面均衡良好。
  • 休克团队中心更多使用肺动脉导管(60% vs 49%;调整OR 1.86;95%CI 1.47-2.35;P<0.001)。
  • 休克团队中心总体机械循环支持使用更少(35% vs 43%;调整OR 0.74;95%CI 0.59-0.95;P=0.016),但先进类型机械循环支持占所有机械循环支持比例更高(53% vs 43%;调整OR 1.73;95%CI 1.19-2.51;P=0.005),而非主动脉内球囊反搏。
  • 休克团队存在与更低的心内科重症监护病房死亡率独立相关(23% vs 29%;调整OR 0.72;95%CI 0.55-0.94;P=0.016)。

临床怎么用

  • 休克团队中心更常获取侵入性血流动力学并使用先进类型机械循环支持,而非主动脉内球囊反搏。
  • 标准化多学科休克团队方法可能改善心源性休克结局。

局限性

  • 本研究为多中心观察性研究,非随机设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-center studies suggest that implementation of multidisciplinary cardiogenic shock (CS) teams is associated with improved CS survival. OBJECTIVES: The aim was to characterize practice patterns and outcomes in the management of CS across multiple centers with versus without shock teams. METHODS: The Critical Care Cardiology Trials Network is a multicenter network of cardiac intensive care units (CICUs) in North America. All consecutive medical admissions to each CICU (n = 24) were captured during annual 2-month collection periods (2017-2019; n = 6,872). Shock management and CICU mortality among centers with versus without shock teams were compared using inverse probability weighting. RESULTS: Ten of the 24 centers had shock teams. Among 1,242 CS admissions, 44% were at shock team centers. The groups were well-balanced with respect to demographics, shock etiology, Sequential Organ Failure Assessment score, biochemical markers of end organ dysfunction, and invasive hemodynamics. Centers with shock teams used more pulmonary artery catheters (60% vs 49%; adjusted odds ratio [OR]: 1.86; 95% CI: 1.47-2.35; P < 0.001), less overall mechanical circulatory support (MCS) (35% vs 43%; adjusted OR: 0.74; 95% CI: 0.59-0.95; P = 0.016), and more advanced types of MCS (53% vs 43% of all MCS; adjusted OR: 1.73; 95% CI: 1.19-2.51; P = 0.005) rather than intra-aortic balloon pumps. The presence of a shock team was independently associated with lower CICU mortality (23% vs 29%; adjusted OR: 0.72; 95% CI: 0.55-0.94; P = 0.016). CONCLUSIONS: In this multicenter observational study, centers with shock teams were more likely to obtain invasive hemodynamics, use advanced types of MCS, and have lower risk-adjusted mortality. A standardized multidisciplinary shock team approach may improve outcomes in CS.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Papolos AI, Kenigsberg BB, Berg DD, et al. Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams. J Am Coll Cardiol. 2021. PMID: 34556316. doi:10.1016/j.jacc.2021.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。